Zydus Lifesciences Ltd - 532321 - Receipt Of Rectification Order Under Section 154 Of The IT Act
Receipt of Rectification Order under section 154 of the IT Act01-07-2024
01-07-2024
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus and Dr. Reddy''s announce licensing agreement for co-marketing of Pertuzumab biosimilar, a critical treatment for breast cancer patients in India.28-06-2024
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of newspaper publication20-06-2024
Zydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Reg 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201519-06-2024
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Participation in Jefferies Corporate Access Day in Ahmedabad16-06-2024
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives tentative approval from USFDA for Azilsartan Medoxomil and Chlorthalidone Tablets.14-06-2024
Zydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for loss of share certificate under Reg 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201504-06-2024
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of shares31-05-2024
Zydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Reg 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201528-05-2024